Dupixent recaptures top Rx, OTC pharma brand spot in April

Dupixent recaptures top Rx, OTC pharma brand spot in April

Source: 
Medical Marketing and Media
snippet: 

This is a return to form for Dupixent, which was one of the top Rx and OTC pharma brands in 2023 but was outperformed by the likes of Vicks and Rinvoq in early 2024.